gBRCA1/2 mutations increase the incidence of breast cancer (BC) by interrupting the homologous recombination repair (HRR) pathway. Although gBRCA1 and gBRCA2 BC have similar clinical profiles, differe
Genome resequencing of B. subtilis mutant strain resulting from random recombinations between strains NCIB 3610 and RO-NN-1. Strain is mostly RO-NN-1 (~80%) but the rest includes randomly swapped snip
Cancer is a genetic disease caused by an accumulation of mutations, however many of these mutations have been identified in pathologically normal tissue. We aim to use laser-capture microscopy (LCM) t
